SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is trending as traders closely monitor the legal and political battle over the Santa Ynez pipeline restart, with significant debate surrounding the Trump administration's efforts to invoke the Defense Production Act to bypass California's state regulatory restrictions. Community discussions are heavily focused on the high short interest and the potential for a major short squeeze, as investors weigh the company's federal support against ongoing local legal opposition.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a surge in market activity driven by the growing demand for modular, off-grid power solutions in AI data centers, further fueled by a strategic partnership with Sustainable Development Capital LLP targeting 450 megawatts of capacity. While investors remain highly critical of past dilution and the lack of signed contracts, sentiment is shifting as market participants focus on the company's established carbon capture technology and its potential to alleviate energy infrastructure bottlenecks.

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

The Grayscale Bitcoin Trust (GBTC) is at the center of a divided market, with traders debating whether ongoing volatility and ETF outflows represent a structural failing or a buying opportunity during a period of macroeconomic uncertainty. Community discussion is heavily focused on the impact of institutional rebalancing, geopolitical tensions, and skepticism regarding the sustainability of current price levels versus long-term bullish theses.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

United Parcel Service is experiencing a notable technical breakout and momentum shift as investors lean into its high dividend yield and turnaround narrative despite ongoing labor union disputes and Amazon volume reductions. The market is actively debating whether recent cost-cutting measures, including workforce and facility consolidations, position the company for a sustained recovery toward higher price levels or if persistent headwinds will continue to weigh on long-term performance.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is experiencing significant market interest driven by robust Q3 earnings, record ASCENIV demand, and raised full-year guidance that signals strong growth momentum. The community is actively debating the stock's long-term valuation, with many investors pointing to upcoming pediatric pipeline developments and the potential for a strategic buyout as key catalysts for a move toward higher price levels.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is trending as investors weigh its upcoming earnings against the broader ride-hailing sector, with community discussion intensely focused on whether the company's valuation and ongoing share buyback program offer a significant buying opportunity. Traders are closely monitoring the stock's sensitivity to Uber's performance and speculating on potential long-term catalysts like autonomous vehicle partnerships and possible acquisition interest.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is experiencing significant market attention and upward momentum following the announcement of a full notice to proceed on a 2.4 billion dollar AI data center power project. Investors are actively debating the company's long-term growth potential and the strategic significance of its partnership with Siemens Energy, while navigating noise from short-seller reports.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is trending as investors digest the recent $5.8 billion merger deal with Valaris, which community members view as a strategic move to create an offshore drilling powerhouse with increased pricing power. The stock is seeing significant options activity and strong retail interest ahead of upcoming earnings, with many focusing on the potential for debt reduction, a strengthening contract backlog, and the sector's long-term recovery.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is seeing intense volatility and record-breaking retail interest as ongoing conflict in the Middle East disrupts the Strait of Hormuz, driving concerns over global supply shocks. While institutional traders weigh the risk of sustained energy inflation against potential government interventions and supply-side waivers, the community remains divided between those betting on further price spikes due to geopolitical escalation and those bracing for a potential correction if diplomacy or strategic releases intervene.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

ASP Isotopes Inc

ASP Isotopes is facing significant downward pressure and intense community scrutiny as investors react to a series of missed operational milestones, including delayed shipments of carbon feedstock and Silicon-28, alongside concerns regarding capital allocation toward unrelated biotech ventures. While some investors maintain a bullish long-term outlook tied to the company's strategic positioning in the nuclear fuel and isotope supply chains, active discussions are dominated by calls for management to prioritize core business execution and provide greater transparency on delayed commercial timelines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innate Pharma's (IPHA) Buy Rating Reaffirmed at BTIG Research

BTIG Research reaffirmed a "buy" rating and issued a $8.00 price target on shares of Innate Pharma in a report on Thursday...

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Short Interest Update

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) was the target of a significant drop in short interest in the month of February. As of February 13th, there was short interest...

Innate Pharma (NASDAQ:IPHA) Shares Up 3.6% - Here's What Happened

Innate Pharma (NASDAQ:IPHA) Trading 3.6% Higher - Time to Buy...

Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026

Regulatory News: Pursuant to the article L. 233-8 II of the French Code de Commerce and the article 223-16 of the French stock-market authorities (Autorit des Marchs Financiers, or AMF) General...

Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced...

Innate Pharma (NASDAQ:IPHA) Stock Price Down 2.2% - Should You Sell?

Innate Pharma (NASDAQ:IPHA) Shares Down 2.2% - Should You Sell...

Innate Pharma (NASDAQ:IPHA) Shares Up 2.3% - Should You Buy?

Innate Pharma (NASDAQ:IPHA) Trading Up 2.3% - Time to Buy...

Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025

Innate Pharma (OTCMKTS:IPHYF) Stock Price Up 13.1% - Time to Buy?

Innate Pharma (OTCMKTS:IPHYF) Trading 13.1% Higher - Time to Buy...

Innate Pharma Releases Its 2026 Financial Calendar

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today released its 2026 financial calendar: March 26, 2026: Publication of 2025 financial statements May...

Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and François Romagné on September 23, 1999 and is headquartered in Marseille, France.

IPHA
Innate Pharma

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest IPHA News

IPHAInnate Pharma